First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
Brain cancers are notoriously difficult to treat, with surgery and radiation continuing to be the main options for these malignancies. ...
Sunday, March 9, 2025
Tag: FirstinClass
Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Manufacturing Issues Block Astellas From a First-in-Class Cancer Drug Approval
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.